Premium Information is available for this item - Upgrade for $1 a day
6505-00-254-5305
Usp Warfarin Sodium Tablets
6505002545305 002545305 C0UMADIN 56-0012-9H
November 2023
7

Marketplace 6505-00-254-5305
Request a Quotation from participating marketplace vendors
Related Documents 6505-00-254-5305 5+ Documents (More...)
/fsg-65/fsc-6505/us 6505-00-254-5305 Usp Warfarin Sodium Tablets 6505002545305 Usp Warfarin Sodium Tablets
Usp Warfarin Sodium Tablets 6505002545305 Warfarin Sodium Tablets 6505002545305 5305 Usp Warfarin
Usp Warfarin Sodium Tablets 6505002545305 Warfarin Sodium Tablets 6505002545305 https/ https https
6505/tr 6505-27-005-7724 Warfarin Sodium Tablets https//www.nsnlookup.com Warfarin Sodium Tablets 6505002545305
Usp Warfarin Sodium Tablets 6505002545305 fsg-65/fsc-6505/us 6505-00-254-5305 Usp Warfarin Sodium
Tablets 6505002545305 6505270057724 us 6505-00-200-1589 https Tablets 6505002545305 https//www.nsnlookup.com
65/fsc-6505/us 6505-00-227-7704 Usp Warfarin Sodium For Injection 002277704 Tablets6505002545305 002545305
C0UMADIN https https 6505/us 6505 https ThinnerSpecial Features [FEAT]Box Of 24 Vials NATO Stock Numbers
Usp Warfarin Sodium Tablets 6505002545305 254-5305Usp Warfarin Sodium Tablets6505002545305 https
052-2856 6505-27-005-7724 6505-00-973-8502 6505-00-200-1589 6505-21-846-1990 6505-01-049-1815 6505-00-254-5305
Restrictions 6505-00-254-5305
6505-00-254-5305 is a Usp Warfarin Sodium Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
End Users 6505-00-254-5305
- NASA (G04V)
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-00-254-5305
- Part Number
- Manufacturer
- Status
- C0UMADIN
- Manufacturer
- 04490 - Bristol-Myers Squibb Pharma Company (Active)
- Incomplete Reference
- Incomplete Reference
- 56-0012-9H
- 04490 - Bristol-Myers Squibb Pharma Company (Active)
- Secondary Buy
- Secondary Buy
Datasheet 6505-00-254-5305
- Characteristic
- Specifications
- Active Medicament Medicinal Strength [AKJA]
- Specifications
- 5.000 Milligrams Warfarin Sodium Active Ingredient
- Administration [CSGS]
- Oral
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 1000.000 Tablets
NATO Stock Numbers Related to 6505-00-254-5305
Freight Information 6505-00-254-5305
6505-00-254-5305 has freight characteristics managed by Tunisia.. 6505-00-254-5305 has a variance between NMFC and UFC when transported by rail and the description should be consulted.